tifluadom has been researched along with cholecystokinin in 2 studies
| Studies (tifluadom) | Trials (tifluadom) | Recent Studies (post-2010) (tifluadom) | Studies (cholecystokinin) | Trials (cholecystokinin) | Recent Studies (post-2010) (cholecystokinin) |
|---|---|---|---|---|---|
| 78 | 0 | 0 | 10,914 | 466 | 1,074 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bock, MG; Chang, RS; Chen, TB; DiPardo, RM; Evans, BE; Freidinger, RM; Lotti, VJ; Rittle, KE; Veber, DF; Whitter, WL | 1 |
| Gericke, M; Morgenstern, R; Ott, T | 1 |
2 other study(ies) available for tifluadom and cholecystokinin
| Article | Year |
|---|---|
Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadom.
Topics: Animals; Benzodiazepines; Brain; Cerebral Cortex; Chemical Phenomena; Chemistry; Cholecystokinin; Dihydromorphine; Guinea Pigs; Molecular Structure; Naloxone; Pancreas; Rats; Receptors, Cholecystokinin; Receptors, Opioid; Receptors, Opioid, kappa; Sincalide | 1990 |
The influence of tifluadom on cholecystokinin-induced antinociception.
Topics: Analgesics; Animals; Benzodiazepines; Cholecystokinin; Dose-Response Relationship, Drug; Drug Interactions; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Morphine | 1990 |